TCR² Therapeutics

TCR² Therapeutics is a discovery-stage pharmaceutical company focused on engineering T cells for cancer treatment. The company's extensive expertise in T cell engagement and deep understanding of T cell receptor biology have enabled the creation of a novel, first-in-class approach that is highly distinct from CAR-T cells and designed to express defined TCR alpha/beta chains.